<?xml version="1.0"?>
<rss version="2.0">
<channel>
  <title>Prevent Blindness America AMD News</title> 
  <link>http://www.preventblindness.org/index.html</link> 
  <description>Prevent Blindness America is the nation's leading volunteer eye health and safety organization dedicated to fighting blindness and saving sight. Focused on promoting a continuum of vision care, Prevent Blindness America touches the lives of millions of people each year through public and professional education, advocacy, certified vision screening training, community and patient service programs and research.</description>
  <language>en-us</language> 
  <pubDate>Mon, 23 Jun 2008 11:12:43 CST</pubDate> 
  <lastBuildDate>Mon, 23 Jun 2008 11:12:43 CST</lastBuildDate> 
  <managingEditor>kwest@preventblindness.org (Ken West)</managingEditor> 
  <webMaster>info@preventblindness.org</webMaster>
  <ttl>720</ttl>
  <copyright>Copyright 2007 Prevent Blindness America</copyright>
  <image>
  	<title>Prevent Blindness America RSS</title>
	<url>http://www.preventblindness.org/RSS/images/pba_rss_icon.gif</url>
	<link>http://www.preventblindness.org/index.html</link>
	<width>88</width>
	<height>31</height>
	<description>Prevent Blindness America</description>
  </image>
  <item>
  <title>Neovista Presents One Year Data on Novel Wet AMD Therapy at ARVO</title> 
  <link>http://www.preventblindness.org/news/releases/062308_1.html</link> 
  <description>Data Analysis Shows Promise of Epiretinal Brachytherapy as NeoVista Progresses with Phase III CABERNET Study.</description> 
  <pubDate>Mon, 23 Jun 2008 11:12:43 CST</pubDate> 
  <guid isPermaLink="true">http://www.preventblindness.org/news/releases/062308_1.html</guid> 
</item>
  <item>
  <title>AMD Clinical Trial</title> 
  <link>http://www.preventblindness.org/news/releases/042208_1.html</link> 
  <description>If you have recently been diagnosed with wet Age-Related Macular Degeneration (AMD), please consider joining the VIEW 1 study, now seeking participants.</description> 
  <pubDate>Wed, 23 Apr 2008 10:14:41 CST</pubDate> 
  <guid isPermaLink="true">http://www.preventblindness.org/news/releases/042208_1.html</guid> 
</item>
 <item>
  <title>Eye Disease Continuing to Increase Among Americans</title> 
  <link>http://www.preventblindness.org/news/releases/040208_1.html</link> 
  <description>Millions of Americans are currently living with age-related eye disease and, according to the latest research from Prevent Blindness America and the National Eye Institute, that number is continuing to climb.  With more than 130 million Americans aged 40 and older, more than 30 million suffer from leading causes of vision loss such as cataract, diabetic retinopathy, macular degeneration and glaucoma.</description> 
  <pubDate>Wed, 2 Apr 2008 16:37:32 CST</pubDate> 
  <guid isPermaLink="true">http://www.preventblindness.org/news/releases/040208_1.html</guid> 
</item>
  <item>
  <title>Little Known Disease Threatens Vision of Millions</title> 
  <link>http://www.preventblindness.org/news/releases/020108_2.html</link> 
  <description>Individually, the costs of outpatient services for AMD patients, between the ages of 40 and 64, are $305 per year, with an additional $110 in medications and vitamins.</description> 
  <pubDate>Fri, 1 Feb 2008 12:12:51 CST</pubDate> 
  <guid isPermaLink="true">http://www.preventblindness.org/news/releases/020108_2.html</guid> 
</item>
  <item>
  <title>Solution to Avastin Access Found through a Joint Effort by the Academy, ASRS and Genentech</title> 
  <link>http://www.preventblindness.org/news/releases/122107_1.html</link> 
  <description>The American Academy of Ophthalmology and the American Society of Retina Specialists (ASRS) report that a solution has been found that addresses Genentech's decision to no longer allow compounding pharmacies to purchase Avastin (bevacizumab) directly from authorized wholesale distributors.</description> 
  <pubDate>Fri, 21 Dec 2007 16:51:08 CST</pubDate> 
  <guid isPermaLink="true">http://www.preventblindness.org/news/releases/122107_1.html</guid> 
</item>
   <item>
  <title>Dietary Lutein/Zeaxanthin May Help Protect Against Age-Related Macular Degeneration</title> 
  <link>http://www.cbsnews.com/stories/2007/09/11/health/webmd/main3249951.shtml</link> 
  <description>Lutein/zeaxanthin may help protect against age-related macular degeneration (AMD), according to the results of a study in the September issue of the Archives of Ophthalmology.</description> 
  <pubDate>Fri, 21 Sep 2007 09:00:00 CST</pubDate> 
  <guid isPermaLink="true">http://www.cbsnews.com/stories/2007/09/11/health/webmd/main3249951.shtml</guid> 
</item>
  <item>
  <title>Economic Impact of Vision Problems in the U.S. Estimated at $51.4 Billion</title> 
  <link>http://www.preventblindness.org/news/releases/041807_1.html</link> 
  <description>Prevent Blindness America today released a new report estimating the costs associated with adult vision problems in the United States at $51.4 billion.</description> 
  <pubDate>Wed, 18 Apr 2007 02:50:21 CST</pubDate> 
  <guid isPermaLink="true">http://www.preventblindness.org/news/releases/041807_1.html</guid> 
</item>
  <item>
  <title>American Academy of Ophthalmology Says Report on Economic Impact of Vision Problems Shows Need for Greater Investment in Prevention and Research</title> 
  <link>http://www.preventblindness.org/news/releases/041807_2.html</link> 
  <description>In response to a study showing America's $51 billion annual cost for vision problems, the American Academy of Ophthalmology today called for the public and private sectors to increase their investment in eye disease and disorder prevention, treatment and research.</description> 
  <pubDate>Wed, 18 Apr 2007 02:48:56 CST</pubDate> 
  <guid isPermaLink="true">http://www.preventblindness.org/news/releases/041807_2.html</guid> 
</item>
  </channel>
  </rss>
